C4A and short chain acyl-CoA dehydrogenase deficiency: At the start of NBS using MS/MS, clinical screening of SCADD or IBDD was primarily based on the biochemical quantification of C4, but the overlap in C4 levels between healthy and affected neonates renders C4 a poor discriminator.